A novel RNA therapy targeting microRNA-132 shows promise in slowing harmful heart remodeling after acute heart attacks in clinical trials.
← News
Medicine Breakthroughs Medicine Breakthroughs Health
RNA therapy slows harmful heart remodeling after heart attack in clinical trial
MicroRNA-132 (MiR-132) Target molecule
Left Ventricular Systolic Dysfunction Condition treated
Clinical Trial Phase Development stage